ALPHAPORT.AI
🇹🇼PF6543
TWDUSD
SectorHealth CareIndustryBiotechWebsitehttp://www.perfectmedical.com.tw
Management
陳宏仁
CEO

Company information

Ticker
6543
Country
Taiwan
Sector
Health Care
Industry
Biotech

PF Business Summary

Perfect Medical Industry Co., Ltd. (PF) operates as a specialized manufacturer of medical consumables, generating revenue primarily through the high-volume production and global distribution of hemodialysis and infusion therapy equipment. The company's business model is centered on transaction-based sales of its proprietary medical devices, which are categorized into primary segments: Hemodialysis Blood Tubing Sets, A.V. Fistula Needle Sets, Safety Infusion and Extension Sets, and Disposable Syringes. Additionally, PF maintains a diversified product line including medical face masks and intravenous (I.V.) locks. Operating production facilities in both Taiwan and Vietnam, the company serves a broad international market spanning Asia, Europe, and Africa. Within the competitive landscape, PF competes directly with major players such as Pacific Hospital Supply (PAHSCO), B. Braun, Fresenius Medical Care, and Nipro Corporation, positioning itself as a cost-efficient, high-quality manufacturing partner with extensive regulatory certifications including ISO 13485 and CE marking. Founded in 1989 and headquartered in Changhua, Taiwan, PF is led by a veteran executive team with deep expertise in medical device engineering and regulatory compliance. The current leadership is headed by Chairman Hsu Kuo-Chi and General Manager (CEO) Chen Hung-Jen, who oversee the company's strategic expansion and operational efficiency. Financial oversight and corporate communications are managed by Yeh Ya-Tung, who serves as the Chief Financial Officer and official spokesperson. The company's board is supported by significant institutional investors, including Tung Da Fa Asset Management Co., Ltd. and Gaoda Technology Co., Ltd., which maintain substantial equity stakes. This leadership group has successfully navigated the company through its 2019 listing on the Taipei Exchange (TPEx) and continues to drive growth through capital increases and technological upgrades in safety-oriented medical consumables.

Updated 2026-03-23 · TW Taiwan public company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.